The Latest in Ankylosing spondylitis

Rheumatology News

High-intensity interval training has sustainable effects in patients with inflammatory arthritis

June 13, 2023

Rheumatology News

Early axial spondyloarthritis diagnosis in referred patients remains stable in most

June 6, 2023

Rheumatology News

Two biologics show no difference in axial spondyloarthritis radiographic progression over 2 years

June 1, 2023

Rheumatology News

AxSpA remission on TNFi seen in half of patients with comorbid IBD

May 25, 2023

Rheumatology News

FDA approves Yuflyma as ninth adalimumab biosimilar

May 24, 2023

Rheumatology News

AxSpA effects may be more severe for Black patients

May 24, 2023

Rheumatology News

FDA approves autoinjector pen for Humira biosimilar, Cyltezo

May 24, 2023

Rheumatology News

Researchers make headway in understanding axSpA diagnostic delay

May 22, 2023

Rheumatology News

MACE, VTE rates compared between TNF and JAK inhibitors for AxSpA and PsA

May 19, 2023

Rheumatology News

Axial spondyloarthritis versus axial psoriatic arthritis: Different entities?

May 9, 2023

Rheumatology News

NSAID use may mask MRI findings in a quarter of spondyloarthritis cases

April 28, 2023

Rheumatology News

Meta-analysis examines cancer risk concern for JAK inhibitors

April 26, 2023

Rheumatology News

Biosimilars and patients: Discussions should address safety, cost, and anxiety about change

March 30, 2023

Rheumatology News

FDA approves new formulation of Hyrimoz adalimumab biosimilar

March 27, 2023

Rheumatology News

What’s holding back physicians from prescribing biosimilars? Four specialties weigh in

February 23, 2023